You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 15, April 21, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Hyperprescribers Feel Pain of Legal Prosecution in Spain

Xavier Bosch, MD

JAMA. 1999;281:1364-1366.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Barcelona—Hyperprescribers will soon be feeling the heat in Spain.

As the result of an ambitious program to find, follow up, and control those it believes write too many prescriptions, Insalud, the Spanish national health insurance organization, has begun disciplinary proceedings against 422 primary care physicians.

From 1994 to 1997, a total of 4284 hyperprescribers were found and the more than 23 million prescriptions they had issued during those years were examined. Physicians who were suspected of fraudulent prescribing (providing patients with blank prescriptions, for example) or taking bribes from drug firms are among the first to be prosecuted. Evaluation is continuing of another 1550 physicians who were judged to be hyperprescribers last year. Although some of the drugs prescribed are of little or no therapeutic efficacy, there has been no evidence of harm to any patients. The program aims to reduce fraud as well as to . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.